NIAID PROGRAM ANNOUNCEMENTS:  UPDATE 

NIH GUIDE, Volume 25, Number 37, November 1, 1996

 

P.T. 34



Keywords:

  Grants Administration/Policy+ 

 

National Institute of Allergy and Infectious Diseases

 

The National Institute of Allergy and Infectious Diseases (NIAID)

published the notice, Continuation and Inactivation of NIAID Program

Announcements, in the NIH GUIDE, Vol. 25, No. 18, June 7, 1996.  This

notice addresses three topics:  (1) it defines the effect of

continuation and inactivation of program announcements on the

potential for funding of grant applications; (2) it announces a new

NIAID policy - that most future NIAID Program Announcements (PAs)

will remain active for three years; and (3) it updates the listing of

NIAID Program Announcements (PAs) being continued and being

inactivated.

 

1.  PA CONTINUATION AND INACTIVATION

 

NIAID gives special consideration for funding, including award of

grants beyond the NIAID percentile and priority score paylines, to

applications submitted in response to active (new and continuing)

PAs.

 

NIAID supports highly scientifically meritorious applications in all

areas of research within its mission.  PA inactivation simply means

that special consideration for funding beyond normal paylines will NO

LONGER be given to applications on the research topics identified in

the inactivated PAs.  However, such applications will be accepted,

reviewed, and considered for funding according the usual procedures.

 

2.  NIAID THREE YEAR PROGRAM ANNOUNCEMENTS

 

Historically, NIAID PAs have been issued for different durations.

Some were issued as open-ended PAs; that is, investigators could

continue to submit applications in response to a PA until NIAID

announced its termination in the NIH Guide.  Others were issued for

one or two or three years of receipt dates following publication.

 

Henceforward, virtually all new NIAID PAs will be issued for three

years of standard receipt dates following their publication in the

NIH Guide for Grants and Contracts.  Each PA will identify the

receipt dates for applications.  This will ensure that there is

adequate time for investigators to develop and propose their research

plans at the same time as ensuring that PAs are not kept active

beyond their useful life.

 

3.  NIAID PA CONTINUATIONS AND INACTIVATIONS.

 

NIAID will continue to support selected previously published PAs and

is inactivating other older PAs.  Further, additional PAs will be

inactivated and new ones published in the future as NIAID continues

to adjust and expand the use of PAs to inform the scientific

community of its areas of current research emphasis (See NIH Guide,

Volume 25, April 19, 1996 for NIAID Notice on Program Announcements

and Research Emphasis Areas).  A listing of all active NIAID PAs plus

a listing of future PAs given concept approval by the National

Advisory Allergy and Infectious Diseases Council is kept current and

can be found on the NIAID WWW site at:

 

http://www.niaid.nih.gov/newsletter/maya/pa-table.htm

 

Clicking on the title of any active PA will link the user to the full

text of the PA.

 

CONTINUATIONS.  NIAID will continue to give special consideration for

funding to applications in response to the following PAs.  For each

PA, the number, title, and date of publication in the NIH Guide for

Grants and Contracts is cited below.  In addition to finding a PA via

the NIAID WWW site (see above), PAs can be obtained from the NIH

Grants and Contracts Home Page (http://www.nih.gov:80/grants).  On

this home page, for PAs published in 1994 or earlier, select "NIH

GUIDE FOR GRANTS AND CONTRACTS"; then select "NIH Guide-Flat Text

Files Printed Edition"; then select the publication date(s) for the

PA(s) in which you are interested.  For PAs published in 1995 and

1996, select "Program Announcements-Full Text."

 

AND ALL NIAID PROGRAM ANNOUNCEMENTS PUBLISHED IN THE NIH GUIDE AFTER

SEPTEMBER 6, 1996.

 

PA-93-041   Minority Investigators in Asthma and Allergy, January 22,

1993

PA-93-108   Behavioral Research in Sexually Transmitted Diseases,

September 3, 1993

PA-94-019   Infectious Causes of Diarrhea/Wasting Syndrome in People

with AIDS, December 17, 1993

PA-94-062   Environmental Agents and Asthma, April 29, 1994

PA-94-092   New Insights into Chronic Fatigue Syndrome, August 4,

1994

PA-94-095   Drug Discovery for Opportunistic Infections Associated

with AIDS, September 16, 1994

PAR-95-047  National Cooperative Drug Discovery Groups, HIV

Treatment, April 14, 1995

PA-95-062   Fellowships and Career Development in Inflammatory Bowel

Disease, May 19, 1995

PA-96-014   Models for HIV Disease and AIDS-related Malignancies,

January 26, 1996

PAR-96-031  NIDDK-NIAID International Collaboration: Small Grant

Awards, March 8, 1996

PA-96-048   Expanded Research on Emerging Diseases, May 3, 1996

PA-96-051   Role of Microbes in Autoimmune and Immune-Mediated

Diseases, May 10, 1996

PA-96-053   Gender in the Pathogenesis of Autoimmunity: Mechanisms,

May 10, 1996

PAR-96-060  Acute Infection and Early Disease Research Network, June

28, 1996

PA-96-061   Modern Vaccines for Mycoses and Measles, June 21, 1996

PA-96-067   Molecular Correlates of Pathogenesis in Parasitic

Diseases, July 26, 1996

PA-96-068   Innovative Drug Discovery Research in AIDS Opportunistic

Infections, August 2, 1996

PA-96-069   Collaborations for Advanced Strategies in Opportunistic

Infections, August 9, 1996

PA-96-070   Chronic Fatigue Syndrome Pathophysiology, August 16, 1996

PA-96-072   Mechanisms of AIDS Pathogenesis, September 6, 1996.

 

INACTIVATIONS.  The following program announcements (PAs) are being

inactivated; NIAID will no longer give special consideration for

funding to applications in response to these PAs.  This notice is

effective immediately and applies to the application receipt

deadlines of February 1, 1997 and after.

 

ALL NIAID-SPONSORED PAs PUBLISHED IN THE NIH GUIDE FOR GRANTS AND

CONTRACTS PRIOR TO NOVEMBER 6, 1992.

 

PA-93-014   The Immunology of Aging, November 6, 1992

PA-93-034   Mucosal Immunity in the Urogenital Tract, January 8, 1993

PA-93-037   Asthma as a T-Cell-Mediated Disease, January 15, 1993

PA-93-042   Cytokines and Adhesion in Allergy and Inflammation,

January 22, 1993

PA-93-049   Neurological Aspects of Lyme Disease, February 6, 1993

PA-93-061   Congenital Cytomegalovirus: Study of Infection and

Sequelae, March 5, 1993

PA-93-085   Biological Factors Influencing Sexual Transmission of

HIV, May 21, 1993

PA-93-090   Basic Rubella Research Leading to Improved Rubella

Vaccines, June 4, 1993

PA-93-096   Research on DNA Vaccines for Infectious Diseases, June

18, 1993

PA-93-105   Helicobacter Pylori Pathogenesis, August 8, 1993

PA-93-114   Autoimmune Endocrine Disease, September 24, 1993

PA-94-023   HIV-Related Therapeutics in Drug Users, January 7, 1994

PA-94-049   Studies on Environmental Toxicants and the Immune System,

March 18, 1994

 

INQUIRIES

 

For questions or further information, contact:

 

Office of the Director

Division of Extramural Activities

National Institute of Allergy and Infectious Diseases

Solar Building, Room 3C20

Bethesda, MD  20892-7610

Telephone:  (301) 496-7291

FAX:  (301) 402-0369

Email:  ac20a@nih.gov


Return to 1996 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.